Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:470-474
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Heuvel, A. F. M.
Right arrow Articles by van Veldhuisen, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Heuvel, A. F. M.
Right arrow Articles by van Veldhuisen, D. J.

CLINICAL STUDY: MYOCARDIAL ISCHEMIA

Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade

Ad F. M. van den Heuvel, MDa, Peter H. J. M. Dunselman, MD, PhDb, Tsjerk Kingma, MSca, Patrick Verhorst, MD, PhDc, Frans Boomsma, PhDd, Wiek H. van Gilst, PhDa and Dirk J. van Veldhuisen, MD, PhD, FACCa

a Department of Cardiology/Thoraxcenter, University Hospital Groningen, Netherlands
b Ignatius Hospital, Breda, Netherlands
c Medisch Spectrum Twente, Enschede, Netherlands
d Department of Internal Medicine I/COEUR, University Hospital Dijkzigt, Rotterdam, Netherlands

Manuscript received March 17, 2000; revised manuscript received August 12, 2000, accepted October 2, 2000.

Reprint requests and correspondence: Prof. Dr. Dirk J. van Veldhuisen, Dept. of Cardiology/Thoraxcenter, University Hospital Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands
d.j.van_veldhuisen{at}thorax.azg.nl

OBJECTIVES

We sought to study the effect of angiotensin-converting enzyme inhibition on exercise-induced myocardial ischemia.

BACKGROUND

Although angiotensin-converting enzyme inhibitors have been shown to reduce ischemic events after myocardial infarction, few data are available regarding their direct anti-ischemic effects in patients with coronary artery disease.

METHODS

We studied 43 patients (average age 63 ± 8 years) with exercise-induced myocardial ischemia (≥0.1 mV ST depression, despite optimal beta blockade) and normal left ventricular function (ejection fraction >0.50). In a double-blind, placebo-controlled parallel design, patients were treated with angiotensin-converting enzyme inhibitor (enalapril 10 mg twice daily) or placebo. Assessments were made after three weeks (short-term) and 12 weeks (long-term).

RESULTS

At baseline, the groups were well matched for all clinical characteristics. After three weeks, there was a slight but not significant increase in time to 0.1 mV ST depression in both groups (p = NS); rate pressure product (RPP = heart rate x systolic blood pressure) was also unaffected. After 12 weeks, however, time to 0.1 mV ST depression further increased in the enalapril group (5.6 ± 1.9 min) but was unchanged in the placebo group (4.4 ± 1.3 min; p < 0.05 between groups). In contrast, RPP was not affected. Concentrations of both atrial and brain natriuretic peptides at peak exercise tended to be lower by enalapril, if compared to placebo (p = NS).

CONCLUSIONS

Angiotensin-converting enzyme inhibition may reduce exercise-induced myocardial ischemia in patients with normal left ventricular function. Further studies are needed to elucidate the mechanisms involved.

Abbreviations and Acronyms
  ANP = atrial natriuretic peptide
  BNP = brain natriuretic peptide
  CAD = coronary artery disease
  LV = left ventricular
  RPP = rate pressure product




This article has been cited by other articles:


Home page
Arch Intern MedHome page
N. Danchin, M. Cucherat, C. Thuillez, E. Durand, Z. Kadri, and P. G. Steg
Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction: An Overview of Long-term Randomized Controlled Trials.
Arch Intern Med, April 10, 2006; 166(7): 787 - 796.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. J. Pepine, J.-L. Rouleau, K. Annis, A. Ducharme, P. Ma, J. Lenis, R. Davies, U. Thadani, B. Chaitman, H. E. Haber, et al.
Effects of angiotensin-converting enzyme inhibition on transient ischemia: The quinapril anti-ischemia and symptoms of angina reduction (QUASAR) trial
J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2049 - 2059.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement